% | $
Quotes you view appear here for quick access.

DexCom, Inc. (DXCM) Message Board

anthonyroberts_lb 44 posts  |  Last Activity: Feb 27, 2012 9:19 AM Member since: Mar 8, 2007
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • anthonyroberts_lb by anthonyroberts_lb Feb 27, 2012 9:19 AM Flag


    In a recent study out of Japan that looked at over 1000 men and women over the age of 60, it was found that people with diabetes (especially type 2) were twice as likely to develop Alzheimer’s. Researchers are now trying to understand the molecular mechanisms that link diabetes to Alzheimer’s. It’s thought that the link may be twofold.

    Nerve cells require a lot of energy to do the work of communicating. They get this energy from oxygen and glucose in the blood. With diabetes, cells lose their ability to respond to insulin, the molecule that transports glucose from the blood into the neurons, and so neurons have to cope with less glucose. Diabetes also often leads to damaged blood vessels, which compromises the delivery of oxygen to the nerves in the brain. Neurons already struggling to communicate despite too much beta-amyloid may lose the battle if glucose and oxygen are deprived.

    Think of the scale arm with a bunch of risk factors piled on it. It’s hovering above ground but fighting to maintain that position. Things aren’t looking good for that synapse, but it’s still managing to function. Those neurons are still able to talk to each other. We aren’t showing any symptoms of Alzheimer’s yet. Add diabetes, and less oxygen and glucose to provide the energy the neurons need, and the scale arm goes crashing to the ground. Now

  • anthonyroberts_lb by anthonyroberts_lb May 22, 2011 9:53 AM Flag


    DexCom Seven and Seven Plus Continuous Glucose Monitoring System

    DexCom Inc.
    San Diego, CA

    Alternate Vendor and method of manufacture of the disposable seal component of the applicator assembly of the Seven and Seven Plus systems. The proposed change applies only to the disposable seal supplier and the method of manufacture; neither the materials nor the final design of the disposable seal are altered. Sensor performance and release specification will also remain unchanged

  • anthonyroberts_lb by anthonyroberts_lb May 1, 2011 8:38 AM Flag

    Why is this brushed under the rug? go to the FDA page under warning letters and take a look what Delta needs to take care of.Its not prity, urine, mouse and rat dropping through out the plane ,it goes on and on.this issue has not been taken care of and is pass due.Just take a look and let us know what you think.

  • anthonyroberts_lb by anthonyroberts_lb Apr 28, 2011 9:22 AM Flag

    Department of Health and Human Services Public Health Service
    Food and Drug Administration
    Atlanta District Office
    60 Eighth Street N.E.
    Atlanta, GA 30309
    Telephone: 404-253-1161

    April 13, 2011


    Richard H. Anderson, CEO
    Delta Airlines, Inc.
    1030 Delta Blvd.
    Atlanta, GA 30354


    Dear Mr. Anderson:

    On January 26 - February 2, 2011, the U.S. Food and Drug Administration (FDA) conducted an inspection of your Delta aircraft # (b)(4) which was located at 1775 Aviation Boulevard, Atlanta, Georgia, during the inspection. This inspection was conducted under the authority of the Public Health Service Act (PHS Act) to determine your firm's compliance with applicable sections of the Interstate Conveyance Sanitation (ICS) regulations (21 Code of Federal Regulations (CFR) Part 1250). These regulations were promulgated pursuant to Section 361 of the PHS Act (42 U.S.C. § 264). Regulations promulgated under this section are necessary to prevent the introduction, transmission, or spread of communicable diseases. This inspection revealed significant violations of 21 CFR Part 1250, under the PHS Act.

    At the conclusion of the inspection, on February 2, 2011, our investigators issued a list of Inspectional Observations (FDA 483) to your firm. As documented on this form (copy enclosed), the following are the significant violations on your aircraft:

  • anthonyroberts_lb by anthonyroberts_lb Apr 28, 2011 9:21 AM Flag


  • anthonyroberts_lb by anthonyroberts_lb Mar 27, 2011 9:51 AM Flag

    another reason the stock price will not go up , THEY HAVE NO MONEY ...... they owe alot more than they can pay back. This CEO sucks and you know it!!!! if they are looking for a buy out why did the try to buy the co, at&t bout? now they are crying foul!! In my opinion this stock is going back to 3.49 real soon. best of luck to u all

  • anthonyroberts_lb by anthonyroberts_lb Mar 14, 2011 9:02 AM Flag


  • anthonyroberts_lb by anthonyroberts_lb Jan 3, 2011 8:15 PM Flag

    why would i want siri when i can have pandora for free ?sports?talk radio ?music /and more ....PANDORA!!!

  • anthonyroberts_lb by anthonyroberts_lb Jan 3, 2011 4:45 PM Flag

    whats up !!!insiders sold over 7million shares last month! :(

  • anthonyroberts_lb by anthonyroberts_lb Nov 9, 2010 5:25 PM Flag

    "In the third quarter, Insulet continued to grow rapidly and deliver solid results, doubling gross profit from a year ago," said Duane DeSisto, President and Chief Executive Officer of Insulet. "We continue to work proactively with the FDA on the next generation OmniPod, as well as on a CGM augmented system in partnership with DexCom. Despite the timing delays due to the changing regulatory landscape, we are committed to remaining the leading innovator in this industry and are hopeful that our next generation pod will be launched in the second half of 2011."

  • anthonyroberts_lb by anthonyroberts_lb Nov 9, 2010 8:18 AM Flag

    Risk Communication AdComm
    Meeting Date: 11/8/10-11/9/10

    Broadcasting Live NOW
    Meeting Description:

    On November 8 and 9, 2010, the Committee will hear and discuss developments in FDA's ongoing communications programs, such as FDA's Strategic Plan for Risk Communication, FDA's Transparency Initiative, and the challenges of effectively communicating with patients and caregivers about appropriate use of medical devices when a patient is prescribed a medical device for home use.

  • anthonyroberts_lb by anthonyroberts_lb Nov 8, 2010 9:01 AM Flag

    .Medical Device Makers Keep Investing Despite Regulatory Uncertainties
    The Bedford Report Provides Analyst Research on Medtronic & St. Jude Medical

    EmailPrint..Companies:Medtronic, Inc.St. Jude Medical Inc..Related Quotes
    Symbol Price Change
    MDT 35.35 0.00

    {"s" : "mdt,stj","k" : "a00,a50,b00,b60,c10,g00,h00,l10,p20,t10,v00","o" : "","j" : ""} Press Release Source: The Bedford Report On Tuesday November 2, 2010, 11:25 am EDT
    NEW YORK, NY--(Marketwire - 11/02/10) - This year medical device makers have been ramping up their Merger and Acquisition activity as well as their R&D budgets. This comes as somewhat of a surprise as the industry is full of uncertainty at the moment. Poor unemployment numbers have made patients reluctant to spend on medical devices, forcing companies to lower their prices. Meanwhile the FDA is reviewing the industry's safety rules and has proposed dozens of changes in the approval program that covers 90 percent of medical devices. The Bedford Report examines the outlook for companies in the Medical Appliances & Equipment Industry and provides research reports on Medtronic, Inc. (NYSE:MDT - News) and St. Jude Medical, Inc. (NYSE:STJ - News). Access to the full company reports can be found at:

  • anthonyroberts_lb by anthonyroberts_lb Nov 8, 2010 7:45 AM Flag

    CARMAT Announces an Agreement with Edwards Lifesciences to Use the Carpentier-Edwards Biological Heart Valves in CARMAT's Artificial Heart
    1:00a ET November 8, 2010 (Business Wire)
    Regulatory News:

    CARMAT (Paris:ALCAR), the designer and developer of the world's most advanced artificial heart, today announced that it has signed an agreement with Edwards Lifesciences, the global leader in the science of heart valves and hemodynamic monitoring. According to this agreement, CARMAT will be using the Carpentier-Edwards' biological heart valves in its artificial heart.

    Carpentier-Edwards biological heart valves were developed by CARMAT co-founder and CSO Professor Alain Carpentier and will be, for the very first time, used in an artificial heart.

    "This partnership with Edwards Lifesciences will enable us to secure a major milestone of our total artificial heart with a view to providing a solution for patients suffering from end-stage heart failure," emphasized CARMAT CEO Marcello Conviti.

    The Carpentier-Edwards biological heart valves with proven design, technology, efficacy, and reliability (recognized in the medical world) are essential components of CARMAT's artificial heart.

    This agreement matches CARMAT's philosophy and very high standards of its artificial heart.

    About CARMAT: CARMAT, the world's most advanced total artificial heart project

    The only credible response for all cases of end-stage heart failure, which is a real public health issue: CARMAT's aim is to be able to provide a response to a major public health issue associated with heart disease, the world's leading cause of death: chronic and acute heart failure. Indeed, this disease currently affects over 100 million patients in developed countries. By pursuing the development of its total artificial heart, CARMAT intends to overcome the well-known shortfall in heart transplants for the tens of thousands of people suffering from heart failure. The result of the combination of two types of unique expertise: the medical expertise of Professor Carpentier, known throughout the world for inventing Carpentier-Edwards(R) heart valves, which are the most used in the world, and the technological expertise of EADS, world aerospace leader. Imitating the natural heart: given its size, its weight, the choice of structural materials and its innovative physiological functions, CARMAT's total artificial heart could, assuming upcoming clinical trials are successful, potentially benefit the lives of tens of thousands of patients a year whilst ensuring there is no risk of rejection and providing them with an unparalleled quality of life. A project leader acknowledged at a European level: with the backing of the European Commission, CARMAT has been granted the largest subsidy ever given to an SME by OSEO; a total of EUR33 million. Substantial involvement of prestigious founders and shareholders: Truffle Capital, the leading European venture capital firm, EADS, the Foundation Alain Carpentier (Carmat's co-founder) and thousands of institutional and individual shareholders who have also shown their confidence in CARMAT.

    For more information:

  • anthonyroberts_lb by anthonyroberts_lb Nov 5, 2010 8:21 AM Flag

    CANNANO up grade this morning 14.00 to 17 a share .(fy on the wall)

  • anthonyroberts_lb by anthonyroberts_lb Sep 19, 2010 9:59 AM Flag

    why are the insiders selling ? or have sold in the 6.00 range, something to think about

  • anthonyroberts_lb by anthonyroberts_lb May 2, 2010 10:23 AM Flag

    Clorox /quotes/comstock/13*!clx/quotes/nls/clx (CLX 64.70, -0.05, -0.08%) is likely to post third-quarter earnings of $1.08 a share

  • anthonyroberts_lb by anthonyroberts_lb Apr 11, 2010 10:20 PM Flag

    pure hase the whole world in its hand ,it has the world in its hand ,it has the whole world in its hands. this liquid steel is a gold mine.good luck to all us longs ,because this little puppy is going to make us rich.

  • you must live in the hood ! are you my neighbor? I love this fee medical shit, In the bill it stated you can walk into ANY cosco fill up your cart with all you want and its freeeeeeeee. people that work there will even load it in your car for you. AHHH THE GOOD OL USA.

  • Is this used cars or new ones ? used care sales are way up ,but i dont think new cars sales are. Siri have deals with new cars ,but not used. this rate of 13.2 million is bogus.

  • anthonyroberts_lb by anthonyroberts_lb Mar 18, 2010 10:38 PM Flag

    your president OBAMA wants you to lose your job so you can help vote for his health plan, (NO JOB ,NO WORK ,NO INSURANCE... Why would he want to help any of us find jobs?

56.995-1.265(-2.17%)10:27 AMEST